Abstract The present invention encompasses novel antibodies and fragments thereof which immunospecifically bind to one or more RSV antigens and compositions comprising said antibody fragments. The present invention encompasses methods preventing respiratory syncytial virus (RSV) infection in a human, comprising administering to said human a prophylactically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject.; The present invention also encompasses methods for treating or ameliorating symptoms associated with a RSV infection in a human, comprising administering to said human a therapeutically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention further encompasses compositions comprising antibodies or fragments thereof that immunospecifically bind to a SRV antigen, and methods using said compositions for detection or diagnosis a RSV infection.
AbstractList The present invention encompasses novel antibodies and fragments thereof which immunospecifically bind to one or more RSV antigens and compositions comprising said antibody fragments. The present invention encompasses methods preventing respiratory syncytial virus (RSV) infection in a human, comprising administering to said human a prophylactically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject.; The present invention also encompasses methods for treating or ameliorating symptoms associated with a RSV infection in a human, comprising administering to said human a therapeutically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention further encompasses compositions comprising antibodies or fragments thereof that immunospecifically bind to a SRV antigen, and methods using said compositions for detection or diagnosis a RSV infection.
Author WU, HERREN
YOUNG, JAMES, F
WATKINS, JEFFRY, D
HUSE, WILLIAM, D
JOHNSON, LESLIE, S
KOENIG, SCOTT
Author_xml – fullname: YOUNG, JAMES, F
– fullname: HUSE, WILLIAM, D
– fullname: JOHNSON, LESLIE, S
– fullname: KOENIG, SCOTT
– fullname: WATKINS, JEFFRY, D
– fullname: WU, HERREN
BookMark eNqNijsKwkAQQLfQwt8d5gJB8ilsRSI2gj9sw5qdNQvJzLIzhd7eIB7A6j14b24mxIQzcz6iduwE2IN1Q6AgiinQc-1YRoAlDdnlev_Kg11AAc8JYuLYvXv7CjImB5rQ6oCkSzP1thdc_bgwsK9vu0OGkRuUaFsk1KY-FVVelJtqm5d_LB-9WTlf
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate Verfahren zur Verabreichung/Dosierung von Anti-RSV-Antikörpern zur Prophylaxe und Behandlung
Procédés d'administration/dosage d'anticorps anti-rsv pour la prophylaxie et le traitement
ExternalDocumentID EP2412384A1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP2412384A13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:59:02 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP2412384A13
Notes Application Number: EP20100010676
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120201&DB=EPODOC&CC=EP&NR=2412384A1
ParticipantIDs epo_espacenet_EP2412384A1
PublicationCentury 2000
PublicationDate 20120201
PublicationDateYYYYMMDD 2012-02-01
PublicationDate_xml – month: 02
  year: 2012
  text: 20120201
  day: 01
PublicationDecade 2010
PublicationYear 2012
RelatedCompanies MEDIMMUNE, LLC
RelatedCompanies_xml – name: MEDIMMUNE, LLC
Score 2.8418567
Snippet The present invention encompasses novel antibodies and fragments thereof which immunospecifically bind to one or more RSV antigens and compositions comprising...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
COMPOSITIONS THEREOF
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
CULTURE MEDIA
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES OF PREPARING SUCH COMPOSITIONS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Title Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120201&DB=EPODOC&locale=&CC=EP&NR=2412384A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVbG-2IPkFmrzrIcgNg-KkDbWWnoru5sNBCQpJqI_39k1jV70NuzCsvlgdubbzHwLcGNknKfCHuqGS4VuZeiKo6ErdI65EeXOLbNd2ZwcT53Ji_W4slcdyLe9MEon9EOJI6JHcfT3Wp3Xm59LrEDVVlYDluNQeR8tvEBr2PEQqTxy42DshcksmPma76OlTeceBioMTtYDEqUdmUVLmf1wOZZNKZvfESU6hN0EFyvqI-iIogf7_vbhtR7sxc3_bjQb16uO4SlWbz1XpMwIbRRvlYzgIC0l3ycIUa7Pn5fKYKWsDiSYkRI8IhHKV_qZVziVkra0_ARIFC78iY57W7c4rMOk_QrzFLpFWYgzIC43XeRkd0IYwnJGlAnLpNRAopIyk9usD_0_lzn_Z-4CDiSg3xXKl9Ct397FFQbgml0r6L4AajmMpQ
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfZ1NS8NAEIaHUsV606pYP_cgvYXafNZDEJukRG3aWGvprexuNhCQpJiI_nwnaxq96G3IwrJ5YXb2SWZmAa7UmPNIGH1FtahQ9BhdcdC3hMLxbES5ec0MqyxODiam_6I_LI1lA5JNLYzsE_ohmyOiR3H090Lu1-ufj1iuzK3MeyzBR9ntaG673YqO-4jyyMbu0PbCqTt1uo6DVncyszFQYXDS7xCUtiwkQklKi2FZlLL-HVFGe7Ad4mRpsQ8Nkbah5WwuXmvDTlD970azcr38AJ4CeddzTrKY0KrjrWwj2IuykvcJSpQos-eFNFhWZgcSPJES3CJRylf6meQ4FJE6tfwQyMibO76Ca1vVOqy8sH4L7QiaaZaKYyAW1yxkshshVKGbA8qErlGqIqhETOMG60Dnz2lO_hm7hJY_D8ar8f3k8RR2S3G_s5XPoFm8vYtzDMYFu5AyfgEjmo-P
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Methods+of+administering%2Fdosing+anti-RSV+antibodies+for+prophylaxis+and+treatment&rft.inventor=YOUNG%2C+JAMES%2C+F&rft.inventor=HUSE%2C+WILLIAM%2C+D&rft.inventor=JOHNSON%2C+LESLIE%2C+S&rft.inventor=KOENIG%2C+SCOTT&rft.inventor=WATKINS%2C+JEFFRY%2C+D&rft.inventor=WU%2C+HERREN&rft.date=2012-02-01&rft.externalDBID=A1&rft.externalDocID=EP2412384A1